Complementary and alternative medicine use amongst patients with cardiovascular disease in Singapore

BMC Complementary and Alternative Medicine

Volumn 16, Issue 1, 2016, Pages

  Teo, Tse Yean ^a   Yap, Jonathan ^b   Shen, Tong ^a   Yeo, Khung Keong ^b,c  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b DEPARTMENT OF CARDIOLOGY   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

Author keywords

Cardiovascular disease; Communication; Complementary and alternative medicine; Singapore

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ORAL ANTIDIABETIC AGENT; WARFARIN;

ADULT; ALTERNATIVE MEDICINE; ARTICLE; BIOLOGICAL THERAPY; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; ENERGY THERAPY; FEMALE; HEALTH BELIEF; HUMAN; INDIAN; MAJOR CLINICAL STUDY; MALAY (PEOPLE); MALE; MANIPULATIVE MEDICINE; OUTPATIENT DEPARTMENT; PATIENT ATTITUDE; PATIENT CARE; PATIENT COMPLIANCE; PREDICTOR VARIABLE; PREVALENCE; SELF ADMINISTRATION TEST; SINGAPORE; TERTIARY CARE CENTER; AGED; CARDIOVASCULAR DISEASES; ETHNOLOGY; MIDDLE AGED; UTILIZATION;

ADULT; AGED; CARDIOVASCULAR DISEASES; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; SINGAPORE;

EID: 84996605242     PISSN: None     EISSN: 14726882     Source Type: Journal    
DOI: 10.1186/s12906-016-1430-4     Document Type: Article

References (37)

1. Lin MC, Nahin R, Gershwin ME, Longhurst JC, Wu KK. State of Complementary and Alternative Medicine in Cardiovascular, Lung, and Blood Research. Circulation. 2001;103(16):2038-42.
2. Eisenberg DM. Trends in Alternative Medicine Use in the United States, 1990-1997: Results of a Follow-up National Survey. JAMA J Am Med Assoc. 1998;280(18):1569-75.
3. Complementary and Alternative Medicine. U.S. National Library of Medicine, National Institutes of Health. 2003. Available from: http://www.nlm.nih.gov/tsd/acquisitions/cdm/subjects24.html. Accessed 30 June 2016.
4. Ernst E. Prevalence of use of complementary/alternative medicine: a systematic review. Bull World Heal Organ. 2000;78(0143):252-7.
5. Fisher P, Ward A. Complementary medicine in Europe. BMJ. 1994;309(6947):107-11.
6. Harris P, Rees R. The prevalence of complementary and alternative medicine use among the general population: a systematic review of the literature. Complement Ther Med. 2000;2:88-96.
7. Lim MK, Sadarangani P, Chan HL, Heng JY. Complementary and alternative medicine use in multiracial Singapore. Complement Ther Med. 2005;13(1):16-24.
8. Chow WH, Chang P, Lee SC, Wong A, Shen HM, Verkooijen HM. Complementary and alternative medicine among Singapore cancer patients. Ann Acad Med Singapore. 2010;39(2):129-35.
9. Shih V, Chiang JYL, Chan A. Complementary and alternative medicine (CAM) usage in Singaporean adult cancer patients. Ann Oncol. 2009;20(4):752-7.
10. Chang KH, Brodie R, Choong MA, Sweeney KJ, Kerin MJ. Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals. BMC Cancer. 2011;11(1):196. BioMed Central Ltd.
11. Fan PEM, Chan MF, Chan YL, Koh SLS. Patterns of complementary and alternative medicine use among a group of patients with type 2 diabetes receiving outpatient care in Singapore. Int J Nurs Pract. 2013;19(May):44-55.
12. Chen C, Chong YJ, Hie SL, Sultana R, Lee SHD, Chan WSD, et al. Complementary and alternative medicines use among pediatric patients with epilepsy in a multiethnic community. Epilepsy Behav. 2016;60:68-74. Elsevier Inc.
13. Eisenberg D, Kessler R, Foster C, Norlock F, Calkins D, Delbanco T. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med. 1993;328:246-52.
14. Adler S, Fosket J. Disclosing complementary and alternative medicine use in the medical encounter: a qualitative study in women with breast cancer. J Fam Pract. 1999;48(6):453-8.
15. Krasuski RA, Michaelis K, Eckart RE, Krasuski RA, Michaelis K, Eckart RE. The cardiovascular patient's perceptions of complementary and alternative medicine. Clin Cardiol. 2006;29:161-4.
16. Niggemann B, Grüber C. Side-effects of complementary and alternative medicine. Allergy. 2003;58(8):707-16.
17. Chagan L, Bernstein D, Cheng JWM, Kirschenbaum HL, Rozenfeld V, Caliendo GC, et al. Use of biological based therapy in patients with cardiovascular diseases in a university-hospital in New York City. BMC Complement Altern Med. 2005;5(1):4.
18. Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521-30.
19. Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.
20. Michael Ho P, Magid DJ, Shetterly SM, Olson KL, Maddox TM, Peterson PN, et al. Medication nonadherence and adverse outcomes in CAD patients. Cardiol Rev. 2009;26(2):22-6.
21. Elmer GW, Lafferty WE, Tyree PT, Lind BK. Potential Interactions between Complementary/Alternative Products and Conventional Medicines in a Medicare Population. Ann Pharmacother. 2007;41(10):1617-24.
22. Miller KL, Liebowitz RS, Newby LK. Complementary and alternative medicine in cardiovascular disease: A review of biologically based approaches. Am Heart J. 2004;147(3):401-11.
23. Yeh GY, Davis RB, Phillips RS. Use of Complementary Therapies in Patients With Cardiovascular Disease. Am J Cardiol. 2006;98(5):673-80.
24. Wood MJ, Stewart RL, Merry H, Johnstone DE, Cox JL. Use of complementary and alternative medical therapies in patients with cardiovascular disease. Am Heart J. 2003;145(5):806-12.
25. Bahall M. Complementary and alternative medicine usage among cardiac patients: a descriptive study. BMC Complement Altern Med. 2015;15:100.
26. Koh H, Ng H, Teo H. A Survey on Knowledge, Attitudes and Usage of Complementary and Alternative Medicine in Singapore. Asia Pac Biotech News. 2004;8(23):1266-70.
27. Shafiq N, Gupta M, Kumari S, Pandhi P. Prevalence and pattern of use of complementary and alternative medicine (CAM) in hypertensive patients of a tertiary care center in India. Int J Clin Pharmacol Ther. 2003;41(7):294-8.
28. Ai AL, Bolling SF. The use of complementary and alternative therapies among middle-aged and older cardiac patients. Am J Med Qual. 2002;17(1):21-7.
29. Grant SJ, Bin Y, Kiat H, Chang D. The use of complementary and alternative medicine by people with cardiovascular disease: a systematic review. BMC Public Health. 2012;12(1):299. BioMed Central Ltd.
30. Kim MS, Smith DH, Yueguo G. Medical Decision Making and Chinese Patients' Self-Construals. Health Commun. 2009;11(3):249-60. Taylor & Francis Group.
31. MacLennan AH, Wilson DH, Taylor AW. Prevalence and cost of alternative medicine in Australia. Lancet (London, England). 1996;347(9001):569-73.
32. Chu F-Y, Yan X, Zhang Z, Xiong X-J, Wang J, Liu H-X. Features of complementary and alternative medicine use by patients with coronary artery disease in Beijing: a cross-sectional study. BMC Complement Altern Med. 2013;13:287.
33. Gohar F, Greenfield SM, Beevers DG, Lip GYH, Jolly K. Self-care and adherence to medication: a survey in the hypertension outpatient clinic. BMC Complement Altern Med. 2008;8(1):4.
34. Oldendick R, Coker AL, Wieland D, Raymond JI, Probst JC, Schell BJ, et al. Population-based survey of complementary and alternative medicine usage, patient satisfaction, and physician involvement. South Carolina Complementary Medicine Program Baseline Research Team. South Med J. 2000;93(4):375-81.
35. Blackmer J, Jefromova L. The use of alternative therapies in the Saskatchewan stroke rehabilitation population. BMC Complement Altern Med. 2002;2:7.
36. Tasaki K, Maskarinec G, Shumay DM, Tatsumura Y, Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: Exploring patients' perspectives. Psychooncology. 2002;11(3):212-20.
37. Yusuf S, Reddy S, Ôunpuu S, Anand S. Global Burden of Cardiovascular Diseases. Circulation.2001;104:2746-2753.